Literature DB >> 18439862

Activation of kappa opioid receptors decreases synaptic transmission and inhibits long-term potentiation in the basolateral amygdala of the mouse.

Volker Huge1, Gerhard Rammes, Antje Beyer, Walter Zieglgänsberger, Shahnaz C Azad.   

Abstract

BACKGROUND: The amygdala plays an important role in the processing of chronic pain and pain memory formation. Particularly, it is involved in the emotional and affective components of the pain circuitry. The role of kappa opioid receptors in these pain conditions is only partly known. The present study investigates the effect of kappa receptor activation on synaptic transmission and synaptic plasticity in the amygdala.
METHODS: Electrophysiological in vitro experiments were carried out in brain slices of male C57BL/6JOlaHsd mice. The effect of the kappa opioid receptor agonist U50,488H (5 microM) and the selective kappa opioid receptor antagonist nor-BNI (3 microM) on field potential (FP) amplitude and the induction of long-term potentiation (LTP) in the basolateral amygdala (BLA) was examined.
RESULTS: High frequency stimulation (HFS) of afferents in the lateral amygdala with two trains of 100 pulses at 50 Hz increased the FP amplitudes to 119+/-2% (mean+/-SEM; n=6) in the BLA. U50,488H decreased synaptic transmission (baseline: 100+/-0.5%; U50,488H: 86.3+/-2.4%; n=6) and blocked the induction of LTP (U50,488H: 100+/-4.1%; HFS: 102.6+/-7%; n=6). The effect on synaptic transmission and on LTP was completely reversed or prevented by application of nor-BNI, which itself had no effect on synaptic transmission or the induction of LTP.
CONCLUSION: Kappa opioid receptor activation decreases synaptic transmission and inhibits the induction of LTP in the BLA of the mouse. These findings may be associated with the effects of kappa opioid agonists in chronic pain and pain memory formation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18439862     DOI: 10.1016/j.ejpain.2008.03.010

Source DB:  PubMed          Journal:  Eur J Pain        ISSN: 1090-3801            Impact factor:   3.931


  15 in total

Review 1.  The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.

Authors:  H A Tejeda; T S Shippenberg; R Henriksson
Journal:  Cell Mol Life Sci       Date:  2011-10-16       Impact factor: 9.261

Review 2.  30 years of dynorphins--new insights on their functions in neuropsychiatric diseases.

Authors:  Christoph Schwarzer
Journal:  Pharmacol Ther       Date:  2009-05-28       Impact factor: 12.310

3.  Adolescent forced swim stress increases social anxiety-like behaviors and alters kappa opioid receptor function in the basolateral amygdala of male rats.

Authors:  E I Varlinskaya; J M Johnson; K R Przybysz; T Deak; M R Diaz
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2019-11-07       Impact factor: 5.067

4.  Potentiation of GluN2C/D NMDA receptor subtypes in the amygdala facilitates the retention of fear and extinction learning in mice.

Authors:  Kevin K Ogden; Alpa Khatri; Stephen F Traynelis; Scott A Heldt
Journal:  Neuropsychopharmacology       Date:  2013-09-06       Impact factor: 7.853

5.  Kappa opioid receptor activation decreases inhibitory transmission and antagonizes alcohol effects in rat central amygdala.

Authors:  Nicholas W Gilpin; Marisa Roberto; George F Koob; Paul Schweitzer
Journal:  Neuropharmacology       Date:  2013-10-21       Impact factor: 5.250

6.  Kappa opioid receptor signaling in the basolateral amygdala regulates conditioned fear and anxiety in rats.

Authors:  Allison T Knoll; John W Muschamp; Stephanie E Sillivan; Deveroux Ferguson; David M Dietz; Edward G Meloni; F Ivy Carroll; Eric J Nestler; Christine Konradi; William A Carlezon
Journal:  Biol Psychiatry       Date:  2011-04-30       Impact factor: 13.382

7.  Age-dependent regulation of GABA transmission by kappa opioid receptors in the basolateral amygdala of Sprague-Dawley rats.

Authors:  K R Przybysz; D F Werner; M R Diaz
Journal:  Neuropharmacology       Date:  2017-02-03       Impact factor: 5.250

Review 8.  Kappa opioid receptor signaling in the brain: Circuitry and implications for treatment.

Authors:  Nicole A Crowley; Thomas L Kash
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-01-12       Impact factor: 5.067

Review 9.  Dopaminergic cellular and circuit contributions to kappa opioid receptor mediated aversion.

Authors:  Elyssa B Margolis; Anushree N Karkhanis
Journal:  Neurochem Int       Date:  2019-07-10       Impact factor: 3.921

10.  Stress-Induced Reinstatement of Nicotine Preference Requires Dynorphin/Kappa Opioid Activity in the Basolateral Amygdala.

Authors:  Stephanie K Nygard; Nicholas J Hourguettes; Gabe G Sobczak; William A Carlezon; Michael R Bruchas
Journal:  J Neurosci       Date:  2016-09-21       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.